PRKN and early-onset autosomal dominant Alzheimer disease: The parkin ubiquitin proteasomal system pathway (WP2359) and Alzheimer’s disease and miRNA effects (WP2059) reveal potential changes in neurobiological and metabolic processes in response to hormonal treatment.